Dudediligence.

Lakewood-Amedex Biotherapeutics, Inc

LABTNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$539,617Mar ’25−$923,291Mar ’26−$3.8MJun ’26
Fiscal years, by the month each ended
LineDec 2025
Operating income−$3.8M
Net income−$3.8M
Operating cash flow−$1.9M
Cash$236,400
Shares outstanding696.4K